GPT and metabolic dysfunction-associated steatotic liver disease: Compared with the earliest systemic review of n-3 PUFAs supplement on NAFLD, similar results that there was a significant benefit for hepatic fat improvement and a trend of AST, ALT improvement were shown in the RCTs [66].